SSI INVESTMENT MANAGEMENT LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 49 filers reported holding HAEMONETICS CORP MASS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$9,431,462
-1.1%
10,872,000
-3.0%
0.77%
+15.2%
Q2 2023$9,536,859
+2.5%
11,208,000
+2.2%
0.67%
+2.3%
Q1 2023$9,305,314
-0.5%
10,967,000
-3.1%
0.65%
+10.3%
Q4 2022$9,350,416
+3.8%
11,316,000
-0.1%
0.59%
-2.0%
Q3 2022$9,006,000
+6.5%
11,327,000
+4.8%
0.60%
+13.7%
Q2 2022$8,459,000
+210.7%
10,808,000
+232.6%
0.53%
+257.0%
Q1 2022$2,723,0003,250,0000.15%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders